HCP
GH icon

Hexagon Capital Partners’s Guardant Health GH Stock Holding History

Hexagon Capital Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21
Closed -$642 – 1868
2024
Q4 		$642 Buy
+21
New +$591 ﹤0.01% 1656
2023
Q3 		– Sell
-6
Closed -$215 – 1432
2023
Q2 		$215 Buy
+6
New +$172 ﹤0.01% 1346

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Hexagon Capital Partners's GH Position: Q1 2025 in Review

Hexagon Capital Partners sold out of Guardant Health (GH) in Q1 2025, closing a stake of 21 shares — an estimated $642 sold.

Hexagon Capital Partners first reported a position in GH in Q2 2023 and held it in 2 quarters. The position peaked at $642 in Q4 2024. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Hexagon Capital Partners reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 21 Guardant Health shares in Q1 2025, an estimated $642.
  • Hexagon Capital Partners first reported a position in Guardant Health in Q2 2023 and held it in 2 quarters.
  • Hexagon Capital Partners's Guardant Health position peaked at $642 in Q4 2024.
  • 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Hexagon Capital Partners's 13F filing for Q1 2025, filed 29 Apr 2025.